Watch list 2017: Top therapeutic areas January 03, 2017 By Mari Edlin Find out about the latest treatment and drug pipeline developments Post-election top policy changes to watch in 2017 January 02, 2017 By Karen Appold While every new year brings change, with Donald Trump elected to become the next president, managed healthcare executives will see more changes than usual in 2017. Healthcare executive compensation changes to watch December 31, 2016 By Rachael Zimlich RN Managed care organizations may be the next target of value-based reimbursements, with bonus payments tied to the health of their company—and its members. Can data analytics aid in end-of-life care decisions? December 29, 2016 By Donna Marbury When it comes to clinicians discussing end-of-life care with patients and their families, too often decisions must be made quickly. Here’s how data analytics can help. Get your plan members to shop around for less-expensive care December 29, 2016 By Judy Packer-Tursman Some health plans are finding success with a new program that rewards patients for seeking out cheaper care. Top pharmacy challenges of 2017 December 28, 2016 By Mari Edlin High drug prices continue to plague payers, but various contributing factors intensify the problem. Will new autoimmune drugs address cost concerns? December 27, 2016 By Erin Bastick PharmD Find out what’s in the drug pipeline for autoimmune disease. Top 10 articles for healthcare executives in 2016 December 27, 2016 By Aubrey Westgate Managed Healthcare Executive's most popular articles this year shed light on the biggest areas of interest to managed care organizations. Read more. How data analytics combats the opioid epidemic Deaths due to opioid abuse have risen sharply—and show no signs of leveling off. Here’s how data analytics can prevent abuse and diversion. How hospitals are doing with the CJR program: CMS releases key data December 24, 2016 By Kelly Price While the second feed may not change providers’ actions in terms of the strategy they’re implementing for the Comprehensive Care for Joint Replacement program, the findings should change their expectations.